cardiovascular outcomes

Original Contribution

Contemporary Trends and Outcomes Associated With the Preprocedural Use of Oral P2Y12 Inhibitors in Patients Undergoing Percutaneous Coronary Intervention: Insights From the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)

04/15/2017

Devraj Sukul, MD¹; Milan Seth, MS¹; Simon R. Dixon, MBChB²; Akshay Khandelwal, MD³; Thomas A. LaLonde, MD⁴; Hitinder S. Gurm, MD^1,5

Devraj Sukul, MD1; Milan Seth, MS1; ...

We sought to describe trends in the use of preprocedural P2Y12 inhibitors and their clinical impact in patients undergoing percutaneous coronary intervention (PCI).

We sought to describe trends in...

04/15/2017

Journal of Invasive Cardiology

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

October 5 ⁠–⁠ October 6

October 14 ⁠–⁠ October 16

October 16 ⁠–⁠ October 19

October 19 ⁠–⁠ October 20

October 26 ⁠–⁠ October 27

October 29 ⁠–⁠ November 2

November 1 ⁠–⁠ November 2

November 6 ⁠–⁠ November 8

November 7 ⁠–⁠ November 10

November 8

See Full Calendar

cardiovascular outcomes

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products